手机版 English 帮助中心
外文文献知网节
文献信息节点
基本信息 摘要 关键词 核心评价 相关文献
Journal | [J] 临床医学研究 Volume 5, Issue 2. 2023.
肺癌肝转移：叙述性综述
作者 : 黄 金富
DOI: 10.12361/2705-0939-05-02-120890
全部来源
获取全文
摘要 / Abstract
背景：肝转移在肺癌患者中很常见，并且仍然是发病率、死亡率和生活质量下降的重要原因，尽管在过去十年中 肺癌远处转移患者的整体管理取得了相当大的进步。了解肝转移的分子发病机制对于提高该患者群体的生存率、保持功能 和控制症状至关重要。方法：在中国知网、Google Scholar 、PubMed 数据库使用以下搜索词搜索，“肝转移与肺癌和病理 生理学”，“肝转移与肺癌”等。以确定与肺癌肝转移相关的论文。结论：肺癌肝转移的预后较差，对于肺癌肝转移患者 应该提供多学科的治疗选择。
关键词 / Keywords
肺癌；肝转移；肿瘤
Related articles / 相关文献
相似文献
作者发文
机构发文
关键词分析
相似文献（说明：与本文内容较接近的文献）
  • [1] Xie S, Xie S, Wu Z, Wu Z, Qi Y, Qi Y, et al.
  • The metastasizing mechanisms of lung cancer: Recent
  • advances and therapeutic challenges. Biomed Pharmacother.
  • 2021;138:111450–111450.
  • [2]Meza R, Meernik C, Jeon J, Cote ML. Lung cancer
  • incidence trends by gender, race and histology in the United
  • States, 1973-2010. PloS One. 2015;10:e0121323.
  • [3]Johnston FM, Johnston FM, Mavros MN, Herman JM,
  • Joseph M. Herman, Pawlik TM. Local Therapies for Hepatic
  • Metastases. J Natl Compr Canc Netw. 2013;11:153–60.
  • [4]Horn SR, Stoltzfus KC, Lehrer EJ, Dawson LA, Tchelebi
  • L, Gusani NJ, et al. Epidemiology of liver metastases. Cancer
  • Epidemiol. 2020;67:101760.
  • [5]Jiang C, Chunyang Jiang, Na Zhang, Xiaoli Hu,
  • Hongyan Wang. Tumor-associated exosomes promote lung
  • cancer metastasis through multiple mechanisms. Mol Cancer.
  • 2021;20:117.
  • [6]Clinical manifestations of lung cancer [Internet]. [cited
  • 2023 Jan 17]. Available from: https://www.medilib.ir/uptodate/
  • show/4641
  • [7] 中华人民共和国国家卫生健康委员会 . 原发性肺癌
  • 诊疗指南（2022 年版）. 中国合理用药探索 . 2022;19:1–28.
  • [8] Li J, Xu W, Kong F, Sun X, Zuo X. Meta-analysis:
  • Accuracy of 18FDG PET-CT for distant metastasis staging in
  • lung cancer patients. Surg Oncol-Oxf. 2013;22:151–5.
  • [9]Wu W, Liao H, Ye W, Li X, Jian Zhang, Zhang J, et al.
  • Fatty liver is a risk factor for liver metastasis in Chinese patients
  • with non-small cell lung cancer. PeerJ. 2019;7.
  • [10]Wu B, Wu B, Wei S, Wei S, Tian J, Tian J, et al.
  • [Comparison of the Survival Time in the Non-small Cell Lung
  • Cancer Patients with Different Organ Metastasis]. Chin J Lung
  • Cancer. 2019;22:105–10.
  • [11]Tseng J-C, Tseng J-C, Chang L-C, Jiang B-Y, Liu
  • Y-C, Chen H-J, et al. Elevated circulating levels of tissue factor_xfffe_positive microvesicles are associated with distant metastasis in
  • lung cancer. J Cancer Res Clin Oncol. 2014;140:61–7.
  • [12]Wang C-F, Peng S-J, Liu R, Yu Y-J, Ge Q-M, Liang
  • R-B, et al. The Combination of CA125 and NSE Is Useful
  • for Predicting Liver Metastasis of Lung Cancer. Dis Markers.
  • 2020;2020:8850873–8850873.
  • [13] 许田慧 , 刘宝刚 . 晚期肺癌肝转移的综合治疗进展 .
  • 现代肿瘤医学 . 2019;27:2200–3.
  • [14]Kylie E Zane, Cloyd JM, Mumtaz K, Mumtaz K,
  • Wadhwa V, Wadhwa V, et al. Metastatic disease to the liver:
  • Locoregional therapy strategies and outcomes. World J Clin
  • Oncol. 2021;12:725–45.
  • [15]Zhong-Yi Zhang, An-Na Jiang, Wei Yang, Kun Yan,
  • Wei Wu, Song Wang, et al. Percutaneous Radiofrequency
  • Ablation Is an Effective Method for Local Control of Liver
  • Metastases From Lung Cancer. Front Oncol. 2022;12.
  • [16]G. Pacella, E. Faiella, C. Altomare, B. Zobel, R. Grasso.
  • Ablative Treatment of Hepatic Recurrence of Lung Cancer Using
  • Electrochemotherapy : A Case Report. Interv Med Clin Imaging.
  • [17] Yang J, Zhang Y, Sun X, Aaron M. Gusdon, Gusdon
  • AM, Song N, et al. The prognostic value of multiorgan metastases
  • in patients with non-small cell lung cancer and its variants: a
  • SEER-based study. J Cancer Res Clin Oncol. 2018;144:1835–
  • 42.
  • [18]Ruhan Zhao, Yunnan Dai, Xinyang Li, Cuimin Zhu.
  • Construction and validation of a nomogram for non small cell
  • lung cancer patients with liver metastases based on a population
  • analysis. Sci Rep. 2022;12.
《中国学术期刊(光盘版)》电子杂志社有限公司 KDN平台基础技术由KBASE 11.0提供
© 2014-2018中国知网(CNKI) 京公网安备11010802020460号 经营性网站备案信息 互联网出版许可证 新出网证(京)字271号 京ICP证040431号